Explore more publications!
Denmark Gazette
Got News to Share?

Press Releases

Antibody Drug Conjugate Market Turns $13.51 Bn into a $32.66 Bn Opportunity by 2035
Apr. 28, 2026

Antibody Drug Conjugate Market Turns $13.51 Bn into a $32.66 Bn Opportunity by 2035

Indeterminate GlobeNewswire, Inc.
Cryopreservation Bags and Freezing Bags Market at $175.1 Mn in 2026; Why the Next $324.3 Mn Phase Matters
Apr. 28, 2026

Cryopreservation Bags and Freezing Bags Market at $175.1 Mn in 2026; Why the Next $324.3 Mn Phase Matters

Indeterminate GlobeNewswire, Inc.
Global Instability Accelerates Push for Domestic Energy Security
Apr. 28, 2026

Global Instability Accelerates Push for Domestic Energy Security

Indeterminate GlobeNewswire, Inc.
Europe Data Center Market Trends in 2026: Liquid Cooling, Power Constraints, and New Site Selection Priorities
Apr. 28, 2026

Europe Data Center Market Trends in 2026: Liquid Cooling, Power Constraints, and New Site Selection Priorities

Neutral EIN Presswire
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
Apr. 27, 2026

Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer

Indeterminate GlobeNewswire, Inc.
Temenos Named a Leader in Digital Banking Engagement Platforms
Apr. 28, 2026

Temenos Named a Leader in Digital Banking Engagement Platforms

Indeterminate GlobeNewswire, Inc.
Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase 3 trial
Apr. 28, 2026

Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase 3 trial

Indeterminate GlobeNewswire, Inc.
CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea
Apr. 28, 2026

CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea

Indeterminate GlobeNewswire, Inc.
AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance
Apr. 27, 2026

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

Indeterminate GlobeNewswire, Inc.
Top-Quality Independent Publishing Service Marks 21 Years in Business
Apr. 27, 2026

Top-Quality Independent Publishing Service Marks 21 Years in Business

Neutral EIN Presswire
Data Center Pioneers Byrne Murphy and William Conway Return to Nordics to Develop 500+ MWs of Data Center Infrastructure
Apr. 27, 2026

Data Center Pioneers Byrne Murphy and William Conway Return to Nordics to Develop 500+ MWs of Data Center Infrastructure

Neutral EIN Presswire
Allarity Therapeutics Announces that the Stenoparib DRP® Test Has Received a Notice of Allowance from the US Patent and Trademark Office
Apr. 27, 2026

Allarity Therapeutics Announces that the Stenoparib DRP® Test Has Received a Notice of Allowance from the US Patent and Trademark Office

Indeterminate GlobeNewswire, Inc.
CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®
Apr. 27, 2026

CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®

Indeterminate GlobeNewswire, Inc.
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
Apr. 27, 2026

Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700

Indeterminate GlobeNewswire, Inc.
Middle Power Deterrence: The Strategic Case for a Canada-Nordic Defence and Governance Alliance to Ensure a 21st Century Pax Arctica
Apr. 23, 2026

Middle Power Deterrence: The Strategic Case for a Canada-Nordic Defence and Governance Alliance to Ensure a 21st Century Pax Arctica

Indeterminate The Arctic Institute
Owner: The Arctic Institute (Non-profit)

The Arctic Institute

Indeterminate
Owned By The Arctic Institute (Non-profit)
Year Founded 2011
Website https://www.thearcticinstitute.org/
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, District of Columbia, Washington
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Heimdal Expands AI Strategy with AI Wingman and Third-Party AI Containment
Apr. 21, 2026

Heimdal Expands AI Strategy with AI Wingman and Third-Party AI Containment

Neutral EIN Presswire
Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions
Apr. 23, 2026

Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire, Inc.
The 8th Annual Scandinavian & Nordic Gaming Show 2026 Brings 8 Awards Honouring the Industry’s Best
Apr. 20, 2026

The 8th Annual Scandinavian & Nordic Gaming Show 2026 Brings 8 Awards Honouring the Industry’s Best

Neutral EIN Presswire
New funding opportunities pave the way for better diagnostics and treatment as well as for engineering efficient biosolutions and replacing critical and scarce resources
Apr. 23, 2026

New funding opportunities pave the way for better diagnostics and treatment as well as for engineering efficient biosolutions and replacing critical and scarce resources

Indeterminate GlobeNewswire, Inc.
New report from Copenhagen Infrastructure Partners: Electrification could cut Europe’s fossil fuel imports 80% by 2050
Apr. 23, 2026

New report from Copenhagen Infrastructure Partners: Electrification could cut Europe’s fossil fuel imports 80% by 2050

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions